News
First Study of a Combination Between the AstraZeneca Vaccine and the First Component of ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'First study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination: Russian Direct Investment Fund '
First study of a combination between the AstraZeneca vaccine and the first component of the Sputnik V vaccine (Sputnik Light) in Azerbaijan shows no serious adverse events or COVID infection cases following the vaccination: Russian Direct Investment Fund (RDIF)— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) July 30, 2021
(The above story first appeared on LatestLY on Jul 30, 2021 02:18 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
